FDA Inspection 1057840 — CSL Behring AG

CSL Behring AG — FEI 3002806716

The FDA completed an inspection of CSL Behring AG on April 13, 2018 in Bern. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 13, 2018
Fiscal Year
2018
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Bern (Switzerland)